Characteristics
|
A convenient set consisting of eight Receptor Tyrosine Kinase (RTK) inhibitors. The eight inhibitors are: 5 mg of Axitinib (ABIN412160), 5 mg of Canertinib (ABIN628985), 5 mg of Gefitinib (ABIN412176), 5 mg of GW2580 (ABIN629002), 25 mg of Lapatinib Ditosylate (ABIN412230), 1 mg of PD-173074 (ABIN412273), 1 mg of SB-431542 (ABIN412272), and 100 mg of Sunitinib Malate (ABIN412205).
|